Biodistribution and intracellular localization of hyaluronan and its nanogels. A strategy to target intracellular s. aureus in persistent skin infections
Intracellular pathogens are a critical challenge for antimicrobial therapies. Staphylococcus aureus (S. aureus)
causes approximately 85% of all skin and soft tissue infections in humans worldwide and more than 30% of
patients develop chronic or recurrent infections within three months, even after appropriate antibacterial
therapies. S. aureus is also one of the most common bacteria found in chronic wounds. Recent evidences suggest
that S. aureus is able to persist within phagolysosomes of skin cells (i.e. keratinocytes, phagocytic cells), being